Reaction

Intra-Abdominal Fluid Collection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,748 reports · 53 co-occurring drugs

As of the last recalculation, Intra-Abdominal Fluid Collection appears in 1,748 FAERS reports alongside 53 co-occurring drug terms. The strongest observed disproportionality signal is REGORAFENIB (PRR 28.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Regorafenib	27	28.1	28.2
Epoprostenol	27	24.9	25.0
Rifaximin	41	23.8	23.9
Trifluridine And Tipiracil	20	22.4	22.5
Alpelisib	15	20.7	20.7
Riociguat	43	16.1	16.1
Rabeprazole	25	13.6	13.6
Selexipag	28	13.1	13.1
Sorafenib	22	12.8	12.8
Octreotide Acetate	31	12.2	12.3
Irinotecan Hydrochloride	13	12.1	12.1
Lenvatinib	31	11.4	11.4
Olaparib	19	10.9	10.9
Niraparib	20	10.8	10.9
Lactulose	33	10.4	10.4
Daptomycin	8	10.4	10.4
Velpatasvir And Sofosbuvir	11	10.3	10.3
Pancrelipase	32	10.0	10.0
Cabozantinib	38	9.6	9.6
Ursosiol	15	9.3	9.3
Lanreotide Acetate	6	9.1	9.1
Ambrisentan	91	9.1	9.1
Piperacillin Sodium,Tazobactam Sodium	20	9.1	9.1
Ursodiol	15	8.3	8.3
Loperamide Hydrochloride Oral	7	8.2	8.2
Pegaspargase	8	7.8	7.8
Ribociclib	20	7.6	7.6
Glecaprevir And Pibrentasvir	7	7.6	7.6
Sildenafil	34	7.1	7.1
Avapritinib	7	6.9	6.9
Sildenafil Powder,	20	6.8	6.8
Macitentan	37	6.5	6.5
Prochlorperazine Maleate	5	6.5	6.5
Ivacaftor	4	6.0	6.0
Acalabrutinib	6	5.9	5.9
Elexacaftor, Tezacaftor, And Ivacaftor	6	5.7	5.7
Risankizumab-Rzaa	38	5.6	5.6
Tenofovir Disoproxil Fumarate Tablets	4	5.5	5.5
Rucaparib	4	5.4	5.4
Vedolizumab	36	5.1	5.1
Treprostinil	50	4.9	4.9
Cortisone Acetate	5	4.8	4.8
Fam-Trastuzumab Deruxtecan-Nxki	4	4.7	4.7
Dabrafenib	8	4.5	4.5
Durvalumab	7	4.1	4.1
Tafamidis	4	4.1	4.1
Axicabtagene Ciloleucel	3	3.6	3.6
Encorafenib	3	3.6	3.6
Pazopanib Hydrochloride	8	3.5	3.5
Venetoclax	18	3.5	3.5
Ledipasvir And Sofosbuvir	5	3.1	3.1
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	8	3.1	3.1
Sacubitril And Valsartan	27	2.8	2.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.